Most users first notice real effects during this period
It reduces inflammation, stimulates new vessel formation, and mobilizes cells to repair damage in muscles, tendons, and skin
Procaspase 3 protein levels showed a time-dependent reduction following incubation with BSO, notably after 48 h, that corresponded with increasing ROS levels
Its side-effect profile in trials has broadly mirrored that of other incretin-based therapies, with nausea, vomiting, diarrhoea, and constipation being the most commonly reported adverse effects, particularly during dose escalation
The following table gives a rough idea of cost differences: For patients, what matters is the long term cost-effectiveness
In turn, ERGOs interaction with other cellular defenses in the body helps to maintain GSH levels